{
  "ticker": "JNJ",
  "target_date": "2025-04-30",
  "actual_date": "2025-04-30",
  "collected_at": "2025-12-08T11:42:18.610029",
  "price": {
    "open": 154.73,
    "high": 154.73,
    "low": 151.62,
    "close": 152.8813934326172,
    "volume": 9598200,
    "change_1d_pct": 0.26,
    "change_7d_pct": -0.39,
    "change_30d_pct": -4.83
  },
  "technicals": {
    "rsi_14": 64.19,
    "sma_20": 150.96,
    "sma_50": 156.29,
    "macd": -0.792,
    "macd_signal": -1.225,
    "macd_histogram": 0.433,
    "bb_upper": 156.51,
    "bb_lower": 145.42,
    "price_vs_sma20_pct": 1.27,
    "price_vs_sma50_pct": -2.18,
    "volume_ratio": 0.9
  },
  "fundamentals": {
    "market_cap": 489014853632,
    "pe_ratio": 19.59171,
    "forward_pe": 19.14812,
    "price_to_book": 6.1605034,
    "price_to_sales": 5.306784,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.33,
    "pct_from_52w_low": 44.28
  },
  "macro": {
    "spy": {
      "price": 551.38,
      "change_1d_pct": 0.04,
      "change_7d_pct": 5.18
    },
    "vix": {
      "level": 24.7,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.18
    },
    "dollar_index": {
      "level": 99.47
    },
    "gold": {
      "price": 3305.0
    },
    "regime": "SIDEWAYS"
  },
  "news": [
    {
      "headline": "Tracking AMG's Yacktman Asset Management Portfolio - Q1 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1746055924,
      "summary": "Read here for Yacktman's Q1 2025 portfolio trends, top holdings, stake changes, and strategies with highlights on Canadian Natural Resources & PepsiCo.",
      "url": "https://finnhub.io/api/news?id=36a8a56c2d2d6f00a78a6b4f9d508bf30461e0432094acffab2700fd67a431ea"
    },
    {
      "headline": "Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems",
      "source": "Yahoo",
      "datetime": 1746046920,
      "summary": "Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Johnson & Johnson (JNJ) and Cisco Systems, Inc. (CSCO), as well as a micro-cap NeurAxis, Inc. (NRXS).",
      "url": "https://finnhub.io/api/news?id=c093f1335c7912e26ecda027ce068191992e96550f94d1685875a269a6a5c236"
    },
    {
      "headline": "Johnson & Johnson (JNJ): Jim Cramer Says \u201cThey Love the Weak Dollar\u201d \u2014 Is This Quiet Giant Back in Favor?",
      "source": "Yahoo",
      "datetime": 1746044228,
      "summary": "We recently published a list of Jim Cramer Reveals Details Of Trump\u2019s Tariff Negotiations & Discusses 10 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discusses. In his recent appearance on CNBC\u2019s Squawk on the ",
      "url": "https://finnhub.io/api/news?id=e65ef0cdf1ac83c487d7c93873f07afaca9f0d0bc63cbeee1e3a988334b75e58"
    },
    {
      "headline": "Is Johnson & Johnson (JNJ) the Best Dow Stock for the Next 12 Months?",
      "source": "Yahoo",
      "datetime": 1746037697,
      "summary": "We recently published a list of The Best and Worst Dow Stocks for the Next 12 Months. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best and worst dow stocks for the next 12 months. The Dow Jones Industrial Average (DJIA), or the Dow, [\u2026]",
      "url": "https://finnhub.io/api/news?id=4a34067628fa1c46a0a2e8fbae72f399391e2f71a8d200867c2bf4dc536d19cf"
    },
    {
      "headline": "Johnson & Johnson (NYSE:JNJ) Gains FDA Approval For IMAAVY\u2122 To Treat Myasthenia Gravis",
      "source": "Yahoo",
      "datetime": 1746034251,
      "summary": "Johnson & Johnson (NYSE:JNJ) recently experienced a 3% price increase in the last quarter, a period during which significant developments occurred for the company. Notably, the FDA granted approval for IMAAVY, a new monoclonal antibody treatment for generalized myasthenia gravis, potentially strengt",
      "url": "https://finnhub.io/api/news?id=af0fe83484030cbe6511ab509f66026ce1c5ed43f4fb9c2bccae9aded3cfaff2"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "8-K",
      "date": "2025-04-30",
      "description": "jnj-20250424.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000141/jnj-20250424.htm"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877468.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000138/xslF345X05/wk-form4_1745877468.xml"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877247.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000135/xslF345X05/wk-form4_1745877247.xml"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877141.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000133/xslF345X05/wk-form4_1745877141.xml"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877052.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000131/xslF345X05/wk-form4_1745877052.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}